News Daily News Year in Review: Pulsed-Field Ablation Again Tops Heart Rhythm News Todd Neale December 24, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Conference News EHRA 2025 Positive Results With Volt Pulsed-Field Ablation System Todd Neale April 07, 2025
News Daily News Biomarker-Based Risk Score Better Predicts Stroke in AF Than Clinical Tools Todd Neale March 19, 2025
News Conference News AHA 2024 Infections No More Likely With Reconditioned Versus New Pacemakers Yael L. Maxwell November 22, 2024
News Conference News ESC 2024 STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines Todd Neale September 06, 2024
News Daily News Patch May Prevail Where Prior Wearable Defibrillators Faltered: Jewel IDE Study Caitlin E. Cox July 30, 2024
News Conference News HRS 2024 CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation L.A. McKeown May 23, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2023 Caitlin E. Cox December 28, 2023
News Conference News EACTS 2023 Combined Surgical and Catheter Ablation Best for Persistent AF Michael O'Riordan October 12, 2023
News Daily News Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability Todd Neale September 13, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2023 Shelley Wood July 31, 2023
News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2022 Caitlin E. Cox July 04, 2022
News Daily News Catheter Ablation May Be Underused for Supraventricular Tachycardia Todd Neale June 10, 2022
News Daily News Skipping Low-Value Cardiovascular Care Could Save Billions: AHA Michael O'Riordan March 01, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021